2 terminated. 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Terminated 2 |
Follow Urogenital Abnormalities: new trials by email Literature Review of Urogenital Abnormalities trials Research Report on Urogenital Abnormalities
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Opioid Reduction Initiative During Outpatient Pediatric Urologic Procedures Using Exparel Exparel 133 miligrams per 10 milliliter injection, Bupivacaine Hydrochloride - Urologic Diseases, Hypospadias | Phase 3 | Terminated | Johns Hopkins University | 104 | 2021-10-01 | 2023-12-26 |
| An Extended Access Program for Bardoxolone Methyl in Patients With CKD (EAGLE) Bardoxolone methyl - Chronic Kidney Diseases, Alport Syndrome | Phase 3 | Terminated | Biogen | 270 | 2019-03-08 | 2025-06-03 |
Cryptorchidism (1) · Hypospadias (1) · Nephritis, Hereditary (1) · Polycystic Kidney, Autosomal Dominant (1) · Renal Insufficiency, Chronic (1) · Testicular Hydrocele (1) · Urologic Diseases (1)
Congenital Abnormalities (2) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2) · Female Urogenital Diseases (2) · Female Urogenital Diseases and Pregnancy Complications (2) · Male Urogenital Diseases (2) · Urogenital Diseases (2) · Abnormalities, Multiple (1) · Chronic Disease (1) · Ciliopathies (1) · Collagen Diseases (1) · Connective Tissue Diseases (1) · Disease Attributes (1) · Endocrine System Diseases (1) · Genetic Diseases, Inborn (1)
Bupivacaine (1) · bardoxolone methyl (1)
Biogen (1) · Johns Hopkins University (1)
United States (2) · Australia (1) · France (1) · Japan (1) · Puerto Rico (1) · Spain (1)
2018 (1)